Senior IT leader with 35 years of experience in strategic planning, assembling effective teams, and project management. People, the user experience, and enhancing efficiency are at the forefront of a strategic vision. Builds teams that can best achieve clients’ goals, while overseeing projects with the right balance of flexibility and punctuality to ensure that projects save time, resources, and money, year after year.

Managed IT projects in the areas of biotechnology, engineering, and process manufacturing, as well as the US Food and Drug Administration (FDA) approval process. This work has honed skills as a systems developer and architect, and business mentor. From 2010 to 2018, served as Director of Enterprise Information Systems for Fujirebio Diagnostics, Inc. In this role negotiated new licensing agreements and spearheaded data governance and data integration programs that have saved the company over one million dollars in fees and development costs.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.